- Raised funding round led by XT Venture Capital, Dec 2007
About
Intratech Medical is developing the Booster balloon catheter therapy to treat patients with acute myocardial infarction by reducing infarct size, thereby improving clinical outcomes. The Booster balloon aims to disrupt the last frontier in ischemic heart disease management and to improve the lives of millions of people worldwide while lowering the associated healthcare costs. Each year approximately 16 million people worldwide will have a heart attack caused by the narrowing or blockage of the coronary arteries supplying blood to the heart muscle. About 6 million of these patients will have an acute myocardial infarction (AMI) requiring immediate revascularization of the clogged artery, which is performed by percutaneous coronary intervention (PCI). Even after a successful revascularization of the patients coronary arteries, in up to 30% of patients the ischemic area around the infarcted heart muscle may still grow and convert into scar tissue, resulting in higher rates of heart failure and mortality. Intratech Medical has had promising preclinical results and is launching its first-in-human clinical study in 2021.
Funding history · 1 round · — total
Q&A
- What is Intratech Medical's primary focus?
- Intratech Medical is developing the Booster balloon catheter therapy to treat patients with acute myocardial infarction by reducing infarct size and improving clinical outcomes.
- When was Intratech Medical founded?
- Intratech Medical was founded in October 2007.
- What is the current status of Intratech Medical?
- Intratech Medical is currently inactive, having ceased to operate in August 2025.
- How many employees does Intratech Medical have?
- Intratech Medical has 1-10 employees.
- Who are the founders of Intratech Medical?
- The founders of Intratech Medical are Eran Hirszowicz (Founder & CTO) and Giora Weisz (CMO).
- What is Intratech Medical's primary sector?
- Intratech Medical's primary sector is Health Tech & Life Sciences.
- Has Intratech Medical conducted any clinical studies?
- Intratech Medical was launching its first-in-human clinical study in 2021, following promising preclinical results.
- Which investor participated in Intratech Medical's funding round in December 2007?
- XT Venture Capital participated in Intratech Medical's funding round in December 2007.
Team · 2
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| linkedin.com/company/5437346 | |
| YouTube | youtube.com/@intratechmedical4224 |
Identifiers & details
| Founded | 2007-10 |
|---|---|
| Employees (exact) | 2 |
| Status reason | Non Active, Aug 2025 ceased to operate |